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PREFACE
The main body of this thesis is a journal article entitled “Electrospun Chitosan
Membranes Loaded with Raspberry Ketone to Induce Differentiation in Pre-Osteoblasts.”
This manuscript will be submitted to the Journal of Tissue Engineering and Regenerative
Medicine.
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ABSTRACT
This study evaluated the potential of adding raspberry ketone (RK) to electrospun
chitosan membranes (ESCMs) to create a bioactive guided bone regeneration (GBR)
membrane capable of stimulating bone cell differentiation. In this study, W-20-17 cells
exposed to 50-200 μg/ml RK showed an increased expression of alkaline phosphatase
(ALP). RK was loaded onto ESCM discs modified by one of three different fatty acid
anhydrides and release profiles were examined. It was found that the RK release profile
was dependent on the type of fatty acid treatment used. RK loaded membranes were then
evaluated for cytocompatibility and osteodifferentiation potential. While the RK released
from the membranes had no cytotoxic effect on the cells, it did not induce
osteodifferentiation. It is speculated that RK levels were not sustained at high enough
concentrations to affect the cells. ESCMs, with a more sustained RK release profile, may
have potential to be used in GBR applications.
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CHAPTER 1: INTRODUCTION
Problem Statement
Periodontal disease or trauma can lead to significant craniofacial bone loss. In
most cases, to regenerate lost craniofacial bone, a bone grafting procedure is required.
However, soft tissue grows faster than bone and tends to migrate into the graft site,
leading to incomplete regeneration. To prevent this, a procedure known as guided bone
regeneration (GBR) was developed in which a barrier membrane is placed over the graft
site to prevent ingrowth of the faster-growing soft tissue. There are around 5,000,000
dental implants placed each year in the U.S. and it is estimated that 40% of these require
GBR procedures1,2. Current membranes made out of expanded polytetrafluoroethylene
(ePTFE), collagen or aliphatic polyesters are not ideal, either being non-degradable, or
having unpredictable degradation rates. Aliphatic polyester membranes such as
poly(lactic acid) produce acidic degradation products, causing inflammation. Currently,
GBR membranes have a relatively high (23-50%) complication rate3. Complications
include membrane exposure and infection which can lead to inadequate bone
regeneration and longer treatment times3.
Attempts to enhance bioactive properties of the membranes to augment bone
regeneration, particularly with collagen membranes have been through addition of bone
morphogenetic protein-2 (BMP-2). However, while BMP-2 is effective in accelerating
bone growth, it is extremely expensive, shows poor release patterns, and has been
associated with side effects such as ectopic bone formation, ankylosis, and bone
resorption4,5. Thus there is a clinical need to improve GBR membranes to provide
effective barrier function while helping stimulate bone regeneration at the graft site.
1

Electrospun chitosan membranes have emerged as a promising alternative to
current GBR membrane materials6-10. Chitosan is biocompatible, biodegradable and has
non-acidic degradation products. Electrospun chitosan membranes have been shown in in
vivo rodent models to be biocompatible, provide effective barrier function, and have
appropriate degradation rates. Furthermore, the nanofiber structure of the electrospun
membranes provides high surface area that is potentially advantageous for drug loading
and delivery. Recently, the natural compound raspberry ketone (RK), a hydroxy-phenolic
compound, has shown potential to stimulate osteoblast differentiation in vitro11. RK
obtained from raspberries, is inexpensive and readily available as a nutraceutical.
However, the local delivery of raspberry ketone as an alternative to BMP-2 for
stimulating and enhancing bone healing and regeneration has not been explored.
The long range goal of this research will be to examine the potential of RK-loaded
electrospun chitosan membranes to be used for guided bone regeneration applications.
Improved bone regeneration in traumatic injuries or implant sites will lead to improved
speech, masticatory function, aesthetics, and overall quality of life for patients. In some
regions of the world, mammalian-derived GBR materials such as collagen are sometimes
met with resistance due to religious or lifestyle beliefs as well as the fear of disease
transmission12. Since chitosan is derived from invertebrates, it can be provided as an
alternative natural GBR material to mammalian-derived materials. Using RK as an
alternative to BMP-2 could dramatically reduce the costs of bone regeneration and
craniofacial/dental implant procedures. If found to be effective in GBR applications, RK
could also be used in other orthopedic applications such as large segmental bone defects
where osteogenesis is important.
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Hypothesis & Rationale
This work aims to take advantage of the biocompatible, biodegradable,
osteoconductive properties and nanofiber structure of electrospun chitosan membranes
and the potential osteogenic properties of RK to create a bioactive guided bone
regeneration membrane that not only provides effective barrier function, but also
stimulates bone growth and differentiation. Therefore the hypothesis of this work is that
RK released from chitosan membranes is effective in stimulating osteo-differentiation
and mineralization in pre-osteoblast cells. The goals are to determine the effects of
chitosan membrane modifications on RK release profiles, the cytocompatibility of RK
loaded membranes, and whether RK released from the membranes has bioactive
properties that induce differentiation of and mineralization by osteoblasts.
The rationale for using electrospun chitosan membranes is that they have been
shown in in vivo rodent models to be biocompatible, provide effective barrier function,
and biodegrade over 3-4 months into non-acidic degradation products. When chitosan is
electrospun, a non-woven nanofibrous structure is created. This structure has
interconnected pores small enough to prevent cell migration through the material, but
large enough to allow for cell-to-cell communication between compartments. The high
surface area of the nanofibers also provides advantages for drug loading and release.
Since RK has shown potential to differentiate stem cells into osteoblasts, the addition of
RK to the electrospun chitosan membranes may result in a bioactive membrane capable
of accelerate the differentiation of a pre-osteoblast cell line into mature osteoblasts.
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Clinical Background
Craniofacial Bone Loss
Periodontal disease is an infection of the tissue surrounding the teeth, particularly
the gums and jaw bone. There are many causes of periodontal disease, but the most
common is poor oral hygiene, which leads to failure to remove plaque. The buildup of
plaque eventually leads to infection. Symptoms of periodontal disease include red,
swollen, painful gums, loose teeth, and painful chewing. The infection can also result in
tooth and/or bone loss in the jaw, affecting mastication, speech, and appearance of
patients. Periodontal disease is a large problem, especially in older populations, affecting
8.5% of adults ages 20-64 and 17.2% of adults over the age of 6513. These numbers are
expected to increase with our country’s aging population. There are also factors that can
put individuals at a higher risk of periodontal disease. These include smoking, diabetes,
some medications, and some illnesses such as AIDS13. Tooth and bone loss may also
occur due to injuries such as assaults, traumatic accidents, or military conflicts14. Assaults
are the most common cause of traumatic facial injury, making up about 70% of cases14.
After an injury, patients can have problems with mastication, speech, and appearance,
similar to periodontal disease. Craniomaxillofacial injuries and periodontal disease often
lead to the use of dental implants in patients. It is estimated that about 5,000,000 dental
implants are placed per year and the US and European dental implant market will reach
$4.2 billion by 20221,15.
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Bone Grafting
Implants involving periodontal disease or craniomaxillofacial injuries often
require bone graft procedures to regenerate the maxillary or mandibular bones in order to
sufficiently hold the implants in place. There are four major types of materials used for
periodontal bone graft procedures: autografts, allografts, xenografts, and alloplasts16.
There are relative advantages and disadvantages of these grafts, though all are used to
treat craniomaxillofacial defects. Autografts are taken from the same patient, often from
the mandible and sometimes the iliac crest. These grafts are the most successful
osteogenic material of all the grafts, but are criticized for causing donor site morbidity
and lack of graft volume16. Allografts are taken from a different patient and are used
either freshly frozen or freeze-dried. Lack of graft volume is not an issue with these grafts
but they do pose a minimal risk of disease transmission. Xenografts are collected from a
different species. Common xenograft species in periodontal regeneration include pigs and
cows. These grafts have concerns with resorption, disease transmission, host rejection,
and in some cases cultural and religious beliefs. Finally, alloplasts are synthetic
biomaterials that are developed to induce bone healing. The most common alloplasts used
are hydroxyapatite, tricalcium phosphate, and bioactive glasses. These materials do not
have the same problems as the organic materials such as limited supply and disease
transmission. However, they do not exhibit any osteogenic properties on their own16.
The dental implant is often placed a few months subsequent to the grafting
procedure, allowing the bone to partially regenerate before the implant is placed17.
However, implant failure rates of up to 10% are still recorded17. A major problem with
this procedure is that the soft tissue surrounding the bone graft site grows faster than
5

bone, often leading to migration of soft tissue into the graft site12. This prevents the bone
from fully regenerating. Without sufficient bone regeneration, the implant may not be
adequately held in place and could have inadequate stability17. Loose implants often lead
to additional procedures, including additional bone grafting, to repair the implant site and
create a more sufficient site. These additional procedures lead to increased stress and pain
for the patient as well as more expenses for the patient, doctor and staff, and insurers.

Osteoblast Differentiation
The cell type primarily responsible for regeneration of bone is the osteoblast.
Bone regeneration requires mesenchymal stromal cells (MSCs) to differentiate into
osteoblasts and for these cells to actively form new bone. MSCs first migrate via blood
vessels to the injury site, where they begin to differentiate18. During differentiation,
preosteoblasts first proliferate and express osteopontin and type-1 collagen, creating a
matrix around the cells. This matrix is mineralized with calcium phosphate crystals in the
presence of alkaline phosphatase (ALP) and other proteins such as bone sialoprotein.
Osteocalcin and osteopontin are expressed following the initial mineralization19. This
process is referred to as osteogenesis. Osteoblasts are relatively slow responders, and
typically do not differentiate rapidly unless signaled by either a biochemical or
mechanical signal19. Therefore, the use of synthetic bone grafting materials alone has
historically shown limited success18. Biological mediators such as BMP-2 and tissue
engineering techniques including guided bone regeneration have recently been used in an
attempt to accelerate the differentiation and osteogenic processes. Faster differentiation
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of osteoblasts leads to faster regeneration of bone and less time between the bone grafting
procedure and the implant placement.

Guided Bone Regeneration
Barrier membranes can be used to separate the soft tissue from the graft site.
These membranes are referred to as guided bone regeneration (GBR) membranes12. The
membranes are placed on top of the grafting material during the grafting procedure and
the soft tissue is then pulled back over the site and closed (Figure 1). The membrane acts
as a mechanical barrier between the two tissue compartments, allowing slower-growing
bone to fully regenerate. The concept of GBR has been around since the 1950s, when it
was explored for both spinal fusion and maxillofacial regeneration applications12. Since
then the field has grown and several different materials have been used.

Figure 1. Bone graft site being covered by a guided bone regeneration barrier
membrane20.
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Current Solutions
Current GBR membrane materials consist of expanded polytetrafluoroethylene
(ePTFE), collagen, or aliphatic polyesters including poly(lactic acid) (PLLA) and
poly(glycolic acid) (PLGA)18,21. ePTFE (Gore-Tex®) membranes are highly
mechanically stable and extremely hydrophobic and therefore act as an effective barrier
to soft tissue, showing significant periodontal regeneration in several clinical trials18. The
membranes are biocompatible and elicit minimal foreign body reaction, but they are not
biodegradable. Since they are not resorbed into the surrounding tissue, ePTFE
membranes require a second procedure to remove the membrane from the graft site. This
second procedure increases costs as well as risks of infection or damage to the newly
regenerated bone, further hindering the implant process18. Collagen membranes, although
less mechanically stable than ePTFE, are highly biocompatible and show some degree of
bioactivity through the activation of surrounding fibroblast cells. Collagen is also
biodegradable and therefore does not require a second procedure for removal. However,
these membranes’ degradation times can vary anywhere between 1-6 months depending
on the degree of crosslinking12. Even membranes that undergo the same cross-linking
methods can have degradation times that vary from 2-8 weeks16. Due to this variability in
degradation times, there have been cases where collagen membranes have been shown to
degrade too quickly to provide an adequate barrier for the regenerating bone, especially
in large bone graft sites consistent with traumatic craniofacial injuries18,21. Aliphatic
thermoplastics, such as PLLA and PLGA are commonly used as synthetic resorbable
GBR membranes. They are popular because some properties, such as degradation time
and mechanical properties, can be customized by changing the composition and chain
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length of the polymers. PLLA and PLGA, like collagen, are also biodegradable, however
they can cause inflammatory, foreign body responses because of their acidic degradation
products. This creates a cytotoxic environment that inhibits new bone formation in the
graft site21,22. Currently, GBR membranes have a relatively high (23-50%) complication
rate. Complications include membrane exposure and infection which can lead to
inadequate bone regeneration for implant placement3.
GBR membranes are often supplemented with bioactive molecules to augment
healing of bone grafting sites. The most commonly used drug for this purpose is bone
morphogenetic protein-2 (BMP-2). BMP-2 is a protein found in large amounts in bone
tissue and is produced by mature osteoblasts. It induces differentiation of mesenchymal
stem cells (MSCs) and pre-osteoblasts through activation of Cbfa1/Osf223. Once
activated, this “master gene” causes MSCs to express an early marker for osteodifferentiation, osteopontin. A collagenous matrix is then formed around the cells. This
matrix can be mineralized in the presence of cell-secreted alkaline phosphatase (ALP)
and bone sialoprotein23. Studies have shown BMP-2 can cause an increase in the rate of
bone regeneration4,5. These studies have led to the development of a commercially
available BMP-2 collagen sponge system, Infuse®, from Medtronic for dental
applications24. However, a consistent delivery system for the drug has yet to be
established. BMP-2’s dosing and release patterns from collagen have been found to be
unpredictable4. The release rate is affected by degree of porosity and interconnectivity of
pores, as well as the degradation mechanics of the material onto which it is loaded.
Typically, supraphysiologic concentrations are used to ensure that BMP-2 is retained at
the treatment site long enough for the bone-forming cells to migrate to the area5. This
9

technique can cause a build-up of BMP-2 at the graft site, leading to adverse reactions
such as ectopic bone formation, bone/tooth root resorption, and ankyloses4,5. The cost of
manufacturing synthetic BMPs is also extremely high, adding to the already high costs of
therapies and research. Thermo-Fisher Scientific lists just 100 µg of BMP-2 Recombinant
Human Protein for over $1,200. The cost limits clinical use of the protein, and makes
research and development of a reliable and sufficient delivery system extremely
expensive.

Chitosan
Chitosan is a biopolymer derived from chitin, a naturally occurring
polysaccharide found in crustacean shells and insect exoskeletons. Chitosan degrades into
short chain oligosaccharides and simple sugars, which are non-acidic and exhibit no
cytotoxicity. It is widely used as a biomaterial because it is non-toxic, osteoconductive,
biodegradable, and biocompatible. In addition, it has been reported to have anti-tumor,
antimicrobial, and antioxidant properties25. Chitosan’s mechanical, degradation, and
bioactive properties can be modified by changing the degree of deacetylation (DDA), or
the number of acetyl groups present. Naturally occurring chitin has a DDA of 0%. The
polymer is considered chitosan at a DDA of 50% or above. Increasing the DDA makes
the structure more crystalline, enhancing the mechanical properties and lengthening the
degradation time26. The molecular weight of chitosan plays a large role in the viscosity
and solubility of the polymer27. Chitosan can be solubilized at relatively low
concentrations in acidic solutions and formed into films, microbeads, sponges, paste,
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scaffolds, or gels. This versatility is another reason it is widely used for biomedical
applications.

Figure 2. Illustration of the removal of acetyl groups from chitin to produce chitosan27.

Electrospinning
Electrospinning is an additive manufacturing technique in which polymers can be
spun into nanofibers using an electrical charge29. An electrospinning setup typically
consists of three components: a voltage source, a conductive spinneret, and a collector
(Figure 3). The voltage source supplies a charge to the spinneret, which creates an
electric field in which the electrostatic forces draw the dissolved polymer out of the
spinneret and onto the collector in the form of nanofibers29. The thickness and structure
of the nanofibers vary depending on the set up of the spinneret and the collector as well
as the charge applied, the distance of the collector, and various atmospheric conditions
such as temperature and humidity.
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Chitosan can be electrospun into a randomly distributed nanofibrous structure
when dissolved in a dilute acid. Solvents that have been used to electrospin chitosan
blends include hexa-fluoro isopropanol (HFIP), trifluoroacetic acid (TFA), and diluted
acetic acid solutions30. However, when spinning pure chitosan, these solvents produce
fibers with non-uniform diameters and small beads were deposited on the collector30.
However, it has been shown that by diluting TFA with dichloromethane (DCM) 70:30,
pure chitosan fibers with uniform diameter and distribution can be produced31. This
structure provides an extremely high surface area that is ideal for drug delivery purposes.
The structure of electrospun chitosan membranes also has a degree of porosity, allowing
cell communication through the membrane while not allowing cells through. There have
been multiple studies that reported new bone formation in critical-sized defects using
electrospun chitosan membranes as a GBR material6-10.

Figure 3. An illustration of a basic electrospinning setup. Not drawn to scale.
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Post-spinning Treatments
The main drawback with electrospun chitosan membranes in GBR applications
has been a high degree of swelling in the fibers, leading to a loss of nanofiber structure or
morphology and porosity32-35. This loss of structure is due to the formation of acidic salts
on the chitosan fibers during the spinning process. In an aqueous environment, these salts
dissolve, lowering the pH in the surrounding area and partially dissolving the chitosan
fibers32. To prevent swelling in the membranes, post-spinning treatments have been used
to stabilize the fibrous structure of the membranes. In an attempt to combat this loss of
structure, crosslinking using glutaraldehyde or genipin has been attempted10,35. However,
these efforts were in an attempt to crosslink the amino groups of chitosan, which are the
site of the acidic salts after spinning. Therefore, there are often not enough free amino
groups for sufficient crosslinking32. Alkaline solutions have also been used in an attempt
to neutralize the acidic salts. However, these solutions are aqueous and still cause
swelling and loss of fibrous structure32. Wu et al. have shown that acylation of the
membranes followed by hydrolysis can prevent deterioration of the nanofibers in
electrospun chitosan while removing any harmful acidic salts introduced during the
electrospinning process. The acylation process adds an acyl group to the chitosan chain,
creating a hydrophobic layer around the fibers32. This prevents the fibers from swelling in
an aqueous environment. Acidic salts can then simply be dissolved out of the fibers in
water while the fibers retain their structure. These treated membranes have shown
compatibility with Saos-2 bone cells in culture and in an in vivo rat calvarial model were
well tolerated, remained cell occlusive, and supported bone healing/regeneration similar
to that of commercial collagen membranes32.
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Raspberry Ketone
RK is a natural phenolic compound found in raspberries. The molecule is used in
flavored candies, soaps, and candles because of its sweet aroma36. It is also sold as a
dietary supplement due to manufacturer claims that it has fat-burning properties.
Recently, RK has been shown to promote the differentiation of stem cells into osteoblasts
in vitro11. When C3H10T1/2 cells were exposed to RK, levels of osteogenic markers
TGF-β, ALP, osteocalcin, and collagen type 1 were increased11. This means that RK may
promote new bone growth in newly differentiated cells. RK is readily soluble in ethanol
and can be loaded onto the membranes in an ethanol solution. Once the ethanol
evaporates, the RK is adsorbed to the surface of the fibers of the membrane. This makes
RK very easy to load onto the chitosan material. The affordability of RK would make it
much more accessible than BMP-2 if it can promote differentiation and mineralization at
similar levels.
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Research Goal & Hypothesis
The goal of this work is to evaluate whether electrospun chitosan membranes
loaded with raspberry ketone (RK) have potential to induce osteo-differentiation in preosteoblasts. It is hypothesized that electrospun chitosan membranes loaded with raspberry
ketone are effective in inducing osteo-differentiation and mineralization in preosteoblasts in vitro. The specific objectives are to determine:
-

RK release kinetics from electrospun chitosan of different post-spinning
treatments

-

At what RK concentration membranes are toxic to cells

-

Whether RK delivery has bioactive properties that induce differentiation of
and mineralization by osteoblasts
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Abstract
Electrospun chitosan membranes (ESCM) modified with short chain fatty acids
have shown promise as biocompatible and biodegradable guided bone regeneration
(GBR) membranes for preventing soft tissue migration into craniofacial bone graft sites.
Raspberry ketone (4-(4-hydroxyphenyl)butan-2-one; RK), a naturally occurring phenolic
compound, has shown potential to stimulate the differentiation of osteoblastic precursors,
thereby accelerating the bone-healing process. The aim of this study was to evaluate the
potential of adding RK to ESCMs to create a bioactive membrane capable of stimulating
bone cell differentiation. This study showed that W-20-17 murine mesenchymal cells
exposed to 50-200 μg/ml RK over 7 days expressed higher levels of alkaline phosphatase
(ALP) than cells exposed to 50-200 ng/ml bone morphogenetic protein-2 (BMP-2),
suggesting that RK has potential as an osteogenic agent. RK was loaded at 100, 250 or
500 μg/1 cm diameter ESCM discs modified by one of three different fatty acid
anhydrides (acetic anhydride, butyric anhydride, or hexanoic anhydride) and the release
patterns were examined. Fourier transformed infrared (FTIR) spectroscopy and water
contact angle measurements showed that the fatty acid anhydrides reacted with the
chitosan and increased the membranes’ hydrophobicity. It was found that the RK release
from the fatty acid-treated membranes followed a burst release pattern with the release
profile dependent on type of fatty acid treatment. RK peak release decreased and duration
of release increased with increasing length of fatty acid chain used. RK loaded
membranes were then evaluated for cytocompatibility and ability to stimulate the
differentiation and mineralization of the W-20-17 cells as compared to BMP-2. RK
released from the membranes had no cytotoxic effect on the cells. However, RK-loaded
17

membranes did not induce differentiation of the pre-osteoblasts. It is speculated that the
decreasing rate of release resulted in RK levels not being sustained at high enough
concentrations to affect the cells. Electrospun chitosan membranes, with a more sustained
RK release profile, may have potential to be used in guided bone regeneration
applications.

Keywords: Guided bone regeneration, chitosan, raspberry ketone
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Introduction
Guided bone regeneration (GBR) membranes are used to cover a dental or
maxillofacial bone graft site to prevent ingrowth of surrounding soft tissue, and to
maximize the amount of healing and regenerated bone1. The membrane acts as a
mechanical barrier between the two tissue compartments, allowing slower-growing bone
to fully regenerate. The concept of GBR has been around since the 1950s, when it was
explored for both spinal fusion and maxillofacial regeneration applications1.
Current GBR membrane materials include expanded polytetrafluoroethylene
(ePTFE), collagen, and aliphatic polyesters including poly(lactic-acid) (PLLA) and
poly(glycolic-acid) (PLGA)2,3. ePTFE (Gore-Tex®) membranes are highly mechanically
stable and hydrophobic and therefore act as a great barrier to soft tissue, showing
significant periodontal regeneration in several clinical trials2-4. However, the membranes
are not biodegradable and require a second procedure to remove the membrane from the
graft site, increasing costs and risk of infection2. Collagen membranes, although less
mechanically stable than ePTFE, are highly biocompatible and show low
immunogenicity5. Collagen membranes are biodegradable and therefore do not require a
second procedure for removal but have been cited as having unpredictable, too rapid
degradation, resulting in inadequate barrier function for regenerating bone2,5. Aliphatic
thermoplastics, such as PLLA and PLGA, are also used as resorbable GBR membranes3.
These synthetic membranes are biodegradable, but they can cause inflammatory, foreign
body responses because of their acidic degradation products, inhibiting new bone
formation at the graft site5,6. Currently, GBR membranes have a relatively high (23-50%)
complication rate. Complications include membrane exposure caused by thin gingival
19

tissues in tension or lack of blood supply and infection, which can lead to inadequate
bone regeneration6.
To help enhance bone regeneration, GBR membranes are often supplemented
with bone morphogenetic protein-2 (BMP-2) to make them more bioactive. Studies have
shown BMP-2 can increase rates of bone regeneration7,8. However, BMP-2’s dosing and
release patterns, particularly from collagen, have been found to be unpredictable and
adverse reactions such as ectopic bone formation, bone/tooth root resorption, and
ankyloses as well as high costs limit its use7,8.
Chitosan is widely used as a biomaterial because it is non-toxic, osteoconductive,
biodegradable, and biocompatible9,10. Nanofibrous membranes can be electrospun from
chitosan dissolved in acidic solutions. There have been multiple studies that reported new
bone formation in critical-sized defects using these electrospun chitosan membranes as a
GBR material11-15. The main drawback with these membranes has been a high degree of
swelling in the fibers16-19. Post-spinning treatments can be used to prevent membrane
swelling. Wu et al. have shown that acylation of the membranes followed by hydrolysis
can prevent deterioration of the nanofibers while removing harmful acidic salts
introduced during the electrospinning process16. In an in vivo rat calvarial model, the
treated membranes were well tolerated, remained cell occlusive, and supported bone
healing/regeneration similar to that of commercial collagen membranes16.
Raspberry Ketone (RK) is a natural phenolic compound found in raspberries and
is commercially available as a nutraceutical because of its reported antioxidative
properties20. RK has been shown to promote the differentiation of C3H10T1/2 murine
stem cells into osteoblasts21. RK has also been shown to increase levels of TGF-β, ALP,
20

osteocalcin, and collagen expressed by these cells in vitro21. This suggests that RK could
promote new bone growth in newly differentiated cells. The affordability of RK would
make it much more economical than BMP-2 if it can promote differentiation and
mineralization at similar levels.
The goal of this work is to determine whether or not electrospun chitosan
membranes loaded with raspberry ketone (RK) induce osteo-differentiation. It is
hypothesized that electrospun chitosan membranes can be loaded with raspberry ketone
and release it over time to promote osteo-differentiation and mineralization in the preosteoblasts in vitro. Chitosan could provide an alternative natural material for GBR
applications that can be made bioactive by supplementation with RK. In addition, RK
could provide a much more financially accessible and safer alternative to BMP-2 as an
osteogenic agent.

Materials and Methods
Fabrication of Electrospun Chitosan Membranes
The electrospinning procedure used was previously reported by Wu et al.16 To
summarize, chitosan (71% DDA, 311.5 kDa, Primex) at 5.5 (w/v)% was dissolved in a
solution containing 70% (v/v) trifluoroacetic acid (TFA) - 30% (v/v) dichloromethane.
The solution was loaded into a 10 ml syringe with a 20 gauge needle and electrospun at a
voltage of 26 kV. The chitosan fibers were collected on non-stick aluminum foil
(Reynolds Wrap VR) wrapped around a rotating collecting plate (38.1 cm diameter disc).
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The collector was positioned approximately 15 cm from the needle tip and rotated at 8.4
RPM to encourage even and random distribution of fibers.

Post-Electrospinning Treatments
To remove the TFA salts that are spun into the membrane and to stabilize the
fibrous structure, the membranes were treated post-spinning by acylation as described by
Wu et al. One of three fatty acids were used: acetic anhydride (AA), butyric anhydride
(BA), or hexanoic anhydride (HA). These fatty acids have a carbon chain length of one,
four, and six carbons, respectively. The electrospun chitosan was cut into 1 cm diameter
discs and placed in a solution of 1 ml pyridine - fatty acid anhydride (1:1) for every 5 mg
of membrane material, adding an acyl group onto the chitosan chain and creating a
hydrophobic layer around the fibers. The membranes were then placed in a 1 L distilled
water bath for 72 hours, with water being refreshed every 24 hours. The water dissolved
the trifluoroacetic acid (TFA) salt out of the membrane that was left behind from the
chitosan being solubilized in TFA pre-spinning.

Membrane Characterization
After post-spinning treatments, the water contact angles were found using the
VCA OptimaXE system to determine hydrophobicity (n=3 per group). Membrane
composition was confirmed using Fourier transform infrared spectroscopy (FTIR,
PerkinElmer Frontier). The nanofiber structure was confirmed using a scanning electron
microscope (SEM, Nova NanoSEM).
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RK Loading and Elution
An elution study was performed to determine the release profile of RK passively
loaded onto electrospun chitosan membranes. Treated membrane discs (1 cm diameter)
were made aseptic using a combination of 70% ethanol and UV light. They were then
loaded at concentrations of either 100, 250, or 500 μg of RK per membrane. These
concentrations were based on the work of Takata et al. using C3H10T1/2 murine stem
cells25. For loading, RK was dissolved in 100% ethanol. The amount of ethanol the
membranes absorb was determined by finding the percent swelling of the membranes by
weighing them before and after soaking in 100% ethanol. The percent swelling
determined how much of the RK-in-ethanol stock should be added to reach the desired
amount of RK per membrane. The RK-ethanol stock was added to the membranes in a
Class II Biological Safety Cabinet and allowed to dry for 30 minutes. The loaded
membranes (n=4 per treatment per loading) were submerged in 1 ml PBS in a 24-well
tissue culture plate and placed in a 37°C incubator. The PBS was collected, frozen at 80°C, and completely refreshed at time intervals of 1, 3, 5, 7, 9, 11, 14, 17 and 21 days.
At the end of the study, the PBS was analyzed for amount of RK using high performance
liquid chromatography (HPLC, Thermo Scientific UltiMate 3000). A mobile phase
consisting of 70% [0.124 M monopotassium phosphate (KH2PO4), 0.08 M dipotassium
phosphate (K2HPO4)] and 30% Acetonitrile (CH3CN) was created for HPLC analysis.
The solution was pumped through a Hypersil GOLD C8 column at a rate of 1 ml/min for
10 minutes. The solution was analyzed using UV-Vis spectroscopy at a wavelength of
209 nm.
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RK Cell Viability Study
Cell viability and growth tests were performed over 12 days with membranes
loaded with 0, 100, 250, or 500 μg of RK per disc using a trans-well system. Membranes
were gas-sterilized using ethylene oxide prior to loading with RK at 100, 250, or 500
μg/membrane as previously outlined. The membranes were then placed in the bottom of
24-well plates and W-20-17 cells, osteoblast precursors, were seeded into trans-well
inserts (0.4 μm pore size, Falcon) at 3200 cells/cm2. The cells were not seeded directly
onto the membranes because of the hydrophobic nature of membranes which could
confound the response of the cells to released RK. A control group containing
membranes without RK and a group with no membranes were also used. The growth
medium used was Dulbecco’s Modification of Eagle’s Medium (DMEM) with 4.5 g/L
glucose, L-glutamine and sodium pyruvate (Corning Inc., Corning, NY, USA)
supplemented with 10% fetal bovine serum (Fisher Scientific), 500 IU/ml penicillin and
500 mg/ml streptomycin. The wells were filled with 1 ml of medium and the plates were
placed in a 37°C incubator. On days 1, 3, 7, and 12 a CellTiter-Glo assay (Promega,
Madison, WI, USA) was performed to estimate cell viability (n=3 per group).

Differentiation of Pre-Osteoblasts
The potential of RK to stimulate osteo-differentiation was examined using the W20-17 mouse stromal cell line (ATCC CRL-2623). These cells were used since they show
a dose-dependent increase in the expression of alkaline phosphatase (ALP) in response to
BMP-2. The cells were seeded at 3200 cells per well in 96 well plates in complete
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DMEM medium and allowed to attached overnight. The medium was removed and
replaced with DMEM medium containing RK at concentrations of 0, 6.25, 12.5, 25, 50,
100, 200, and 400 μg/ml. Media were also prepared with the RK concentrations spiked
with 25 ng/ml BMP-2 (GoldBio, St. Louis, MO, USA) in order to investigate the
possibility of synergistic or additive effects between RK and BMP-2 on ALP production.
Medium containing BMP-2 at 0, 6.25, 12.5, 25, 50, 100, 200, and 400 ng/ml media were
used as control. The cells were kept in a 37°C 5% CO2 water-jacketed incubator for 7
days with media being replaced at 3 and 5 days with the same formulations. Test plates
were removed after 1, 3, and 7 days (n=4 per group per time point). At each time point,
the medium was removed and replaced with fresh distilled/deionized water and then the
plates were subjected to 3 freeze-thaw cycles to lyse the cells for measurement of ALP
activity using QuantiChromTM Alkaline Phosphatase Assay (BioAssay Systems,
Hayward, CA, USA) and DNA using the Quant-IT PicoGreen DNA assay (Invitrogen).

Mineralization Study
Treated membranes were gas-sterilized and loaded with RK concentrations of
100, 250, or 500 μg/membrane as described. The membranes were placed in trans-well
inserts and W-20-17 cells were seeded in bottom of 24-well plates. Control groups
containing trans-wells with membranes without RK and wells with no membranes. Cells
were cultured in 1 ml of mineralizing medium (DMEM complete growth medium
supplemented with 5mM beta-glycerolphosphate and 50µg/ml ascorbic acid). Cells with
no membranes grown in mineralizing media supplemented with 25ng/ml BMP-2 were
also used as controls. The plates were then placed in a 37°C incubator. ALP and
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PicoGreen assays were performed on Days 1, 7, 14, and 21 (n=4 per group per time
point). On days 14 and 21, the amount of calcium phosphate deposition as an indicator of
mineralization for each group was analyzed using a quantitative Calcium Assay (Pointe
Scientific, Inc., Canton, MI). On Day 21, cells were fixed using a 3.7% formalin solution
and stained with Alizarin Red S (2%, MP Biomedical) for qualitative analysis (n=1 per
group).

Statistical Analysis
A mixed model linear regression was performed on the release data to detect
interactions based on factors of time, treatment, and dosage. ANOVA was used to
determine where differences existed between groups. Statistical significance was declared
when p < 0.05.

Results
Water Contact Angle
The contact angles appeared to increase with increasing fatty acid chain length,
although no statistical difference was found (Table I).
Table I. Water Contact Angles of Different Fatty Acid
Treatments (n=3 per group)
Treatment
Contact angle (degrees)
Acetic Anhydride
57.1±13.3
Butyric Anhydride
66.0±39.6
Hexanoic Anhydride
100.1±16.3
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SEM
SEM images confirmed that the nanofiber structure of the membranes was
maintained after post-spinning treatments (Figure 1). The AA, BA, and HA-treated
membranes appeared to show minimal swelling of the fibers due to the aqueous solutions
used in the treatments.

Figure 1. SEM images of an untreated membrane (A), AA-treated membrane (B), BAtreated membrane (C), and HA-treated membrane (D) (5,000x mag).

FTIR
FTIR data confirmed that the post-spinning treatments removed the TFA salts
from the membranes. The three small peaks at 722, 802 and 841 cm-1 are associated with
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the presence of trifluoroacetic salts in the membrane16. The peaks are present and welldefined in the as spun membrane (Figure 2). However, for all three of the pyridine-fatty
acid treatments, the peaks are not present. The peak starting around 1742 cm-1
corresponds to the acyl (C=O) groups which support the reaction of the fatty acids to the
hydroxyl (OH) groups of chitosan. The peak observed between 2900 and 3000 cm-1
correspond to the methyl groups present.

Acyl Group Peak

TFA Salt Peaks

3250
3172
3094
3016
2938
2860
2782
2704
2626
2548
2470
2392
2314
2236
2158
2080
2002
1924
1846
1768
1690
1612
1534
1456
1378
1300
1222
1144
1066
988
910
832
754
676

Absorbance

Methyl Group Peak

Wavenumbers (cm-1)
HA-Treated

BA-Treated

AA-Treated

As Spun

Figure 2. FTIR data for the as spun and treated electrospun chitosan membranes. The
peaks associated with methyl groups, acyl groups, and TFA salts have been highlighted.
(n=1 per group).
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RK Loading and Elution
All membranes showed a burst release profile with the largest amount of RK
being released within the first day (Figure 3). However, the amount of RK loaded and the
type of membrane treatment both had a statistically significant effect on amounts and
duration of release (p-value < 0.0001). Membranes treated with acetic anhydride released
RK the most quickly, no matter the loading dosage (Figure 3A). The AA-treated
membranes loaded with 500 μg RK showed trace amounts released on Day 9, but the
other dosages released all RK by Day 5. The butyric anhydride-treated membranes
showed a slightly more sustained release, showing release up to Day 9 (Figure 3B).
Hexanoic anhydride-treated membranes showed the longest release pattern. These
membranes still showed RK release up to 14 days after loading (Figure 3C). No
membranes showed any significant release on Days 17 or 21.
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Figure 3. RK release from electrospun chitosan membranes loaded with 500 μg (A), 250
μg (B), or 100 μg (C). Inset graphs indicate elution for Days 7-14 (n=4 per group). Bars
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are means and error bars are standard deviations. *Statistically significant difference
(p<0.05).

RK Cell Viability Study
In general, there were only minor statistical differences in the growth of the cells
exposed to the membranes with and without RK loading and the controls (Figure 4). The
differences were detected primarily at the Day 1 time point. Other than Day 1, only two
significant differences were found between test membranes and the no membrane control
group: at Day 3 for the AA-treated membrane loaded with 250 μg RK and at Day 12 for
the BA-treated membrane loaded with 100 μg RK. While these were statistically different
the real differences were small and may not be of practical importance. Overall, the assay
showed similar viability of cells in trans-wells exposed to RK loaded membranes as
compared to wells with non-loaded membranes and no membranes at all.
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Figure 4. Effect of electrospun chitosan membranes loaded with 500 μg RK (A), 250 μg
RK (B), and 100 μg RK (C) on growth of W-20-17 cells over 12 days (n=3 per group).
*Statistically significant difference.

Pre-Osteoblast Differentiation
The results of the differentiation study examining ALP expression are shown in
Figure 5. There were no statistical differences detected between cells exposed to RK, RK
spiked with BMP-2, or BMP-2 at Day 1 (Figure 5A). On Days 3 and 7, statistical
differences in ALP expression by the cells exposed to different medium were detected
(p<0.05). ALP expressions increased with increasing amounts of BMP-2 from 50ng/ml to
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400ng/ml. ALP expression was also increased with increasing amounts of RK from 50 μg
to 200 μg. There was no effect of spiking RK solutions with 25 ng BMP-2. The
expression of ALP by cells exposed to 50 μg to 200 μg RK were statistically greater than
cells exposed to 50 ng to 200ng of BMP-2 on Day 7. Only the cells supplemented with
400 ng BMP-2 showed a significantly (p<0.05) higher ALP production than cells with
400 µg RK by Day 7, even when spiked with 25 ng BMP-2. This is likely due to some
degree of toxicity associated with the RK at such a high dose, which was confirmed by
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Figure 5. ALP expression of W-20-17 cells normalized by DNA on Day 1 (A), Day 3
(B), and Day 7 (C). Cells were exposed to either RK, BMP-2, or RK spiked with 25 ng

33

BMP-2 (n=4 per group). Bars are means and error bars are standard deviations.
*Statistically significant difference (p<0.05).

Mineralization Study
ALP expressions of the W-20-17 cells showed only minor statistical differences
between the groups with RK-loaded membranes and the control group containing no
membranes (Figure 6). There were no statistical differences between RK loading
concentrations for the HA-treated membranes. The positive control group containing 25
ng/ml BMP-2 showed approximately 50x higher ALP levels at Day 14. Overall, ALP
levels were the highest on Day14, dropping lower on Day 21.
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Figure 6. ALP expression of W-20-17 cells exposed to AA-treated membranes (A), BAtreated membranes (B), or HA-treated membranes (C) loaded with RK and the BMP-2
control (D) over 21 days (n=4 per group).

Calcium Assay and Alizarin Red S Staining
As with the ALP expression, there were very few differences in calcium levels
detected between the test groups and the negative control (Figure 7). The largest
difference occurred in the HA-treated group loaded with 250 μg RK on Day 14.
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However, on Day 21 this group was not different from the negative control. The BMP-2
group showed calcium levels about 30x higher than the other groups on Day 21. The
BMP-2 group also showed approximately a 100% increase in calcium levels from Day 14
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Figure 7. Calcium concentration of media from cells exposed to membranes loaded with
500 μg RK (A), 250 μg RK (B), 100 μg RK (C), and no RK (D) and media supplemented
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with 25 ng/ml BMP-2 (E) (n=4 per group). Bars are means and error bars are standard
deviations. *Statistically significant difference (p<0.05).

Cells stained with 2% Alizarin Red S on Day 21 are shown in Figure 8. The
BMP-2 group showed strong staining with Alizarin Red S (Figure 8A). The no membrane
group showed little to no staining. All of the test membrane groups also exhibited little to
no staining, similar to the no-membrane group, and much less staining than the BMP-2
group.

A.

C.

B.

Figure 8. Cells exposed to no membrane (A), an HA-treated membrane loaded with 250
μg RK (B), and 25 ng/ml BMP-2 media (C) for 21 days stained with 2% Alizarin Red S
for calcium deposition (n=1 per group).
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Discussion
A GBR membrane provides a barrier to soft tissue infiltration during bone
grafting procedures. Acylated electrospun chitosan membranes have been explored as
potential GBR membranes because they are biocompatible, biodegradable, and their
nanofiber structure allows cell-to-cell communication between compartments. RK is a
molecule that has been shown to have osteogenic potential21. After loading with RK,
acylated membranes released RK for up to 14 days, with tailorable release by
modification of membrane acyl group. The ability to locally deliver RK from electrospun
chitosan membranes may result in a bioactive GBR membrane that is able to enhance
bone regeneration.
As higher water contact angles are associated with hydrophobic characteristics,
the increase observed suggests that the membranes were made more hydrophobic by
treating with longer fatty acid chains. The large standard deviations are likely due to the
small sample size (n=3 per group). The treatments did not have any effect on the structure
of the nanofibers, as shown by the SEM images. It was also verified via FTIR that the
pyridine-fatty acid treatments removed the TFA salts introduced during the
electrospinning process and the addition of the fatty acid chains on the chitosan
molecules was successful. These results were consistent with those obtained by Wu et
al16.
The burst release of RK from the membranes was able to be manipulated by
treating with increasing fatty acid chain length. AA-treated membranes showed
approximately a 90% decrease in RK released between Day 1 and Day 3. BA-treated
membranes showed an 85% decrease and HA-treated membranes showed a 70% decrease
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in the same span. With increasing length of fatty acid chains, RK also showed a more
prolonged release profile from 5 to 11 days. The decrease in peak release and the longer
release time periods could be attributed to the increasing hydrophobicity of the
membranes due to increasing fatty acid chain length and the hydrophobic character of the
aromatic ring and butanone group of the RK molecule. A hydrophobic molecule is less
likely to be released from the membrane into an aqueous environment if the membrane is
also hydrophobic22. In addition, the degree of interaction of the butanone group of RK
likely increases with FA chain length resulting in slower release rates, as illustrated in
Figure 9. Predictable modification of the release profile of RK from electrospun chitosan
membranes makes the combination a promising system for GBR drug delivery. These
membrane modifications may have advantages in the loading and release of other
hydrophobic drugs, such as hydrophobic antibiotics or anti-cancer drugs23. Selection of
acyl group length could be used to design rapid release, intermediate release, or extended
release patterns, depending on what dosing pattern is appropriate for biological activity.

Figure 9. An illustration of the possible interaction between the fatty acid chains bonded
to the chitosan molecule and the butanone group of RK.
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The results of the W-20-17 cell viability study showed that electrospun chitosan
membranes loaded with RK at concentrations of up to 500 μg/membrane had little effect
on the viability or growth of W-20-17 cells. This is significant because it suggests that
electrospun chitosan membranes loaded with RK would not be toxic to osteoblastic
precursors up to a loading concentration of 500 μg. Takata et al. showed that C3H10T1/2
stem cells exposed to 200 μg/ml and 500 μg/ml RK for 72 hours showed a significant
decrease in viability21. However, even when 500 μg RK was loaded onto membranes, the
RK concentration never reached a level of 500 μg/ml and maximum concentrations above
200 μg/ml occurred only for 24 hours in our elution study. By Day 3, the RK release
concentrations were at non-toxic levels of 100 μg/ml or less. By controlling the loading
levels, this study showed that non-toxic elution of RK could be achieved. It is crucial that
RK is not toxic to osteoblastic precursors or stem cells for maximum healing and bone
regeneration. Treated membranes themselves did not release any cytotoxic materials, as
cells exposed to unloaded membranes showed normal growth patterns. These results were
consistent with the viability study performed by Wu et al. and Norowski et al. using
SAOS-2 human osteoblastic cells11,16. This biocompatibility compares to other GBR
materials such as ePTFE and collagen2.
In the experiment evaluating effects of RK on induction of ALP in the W-20-17
cells as an indicator of osteogenic effects, RK solutions were tested with and without
being spiked with 25 ng/ml of BMP-2. A low concentration of BMP-2 was selected that
is known have a positive effect on inducing ALP expression in the cells but not so large
as to overwhelm any possible effect of RK. Increasing BMP-2 concentrations exhibited
increases in ALP expression, consistent with other similar studies24. There was also an
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increase in ALP expression with increasing RK concentration up to 400 μg/ml. However,
the high expression of ALP due to the 400 μg/ml RK solution may be an artifact of low
cell numbers due to a decrease in cell viability at this high RK concentration. At nontoxic concentrations of RK, the amount of ALP expressed was similar to or higher than
the BMP-2 group, suggesting that RK can induce differentiation of pre-osteoblasts. These
results agreed with the findings of Takata et al. that 100 μg/ml RK approximately
doubled ALP expression in C3H10T1/2 murine stem cells in the presence of 300 ng/ml
BMP-221. Interestingly, with W-20-17 cells there did not appear to be any additive,
antagonistic, or synergistic interaction between RK and BMP-2. The group of RK spiked
with BMP-2 produced similar levels of ALP to the RK group, suggesting that RK is
capable of inducing differentiation on its own. The exact mechanism of RK inducing
differentiation is unclear, and will need to be investigated in the future.
RK-loaded membranes did not induce higher ALP expression than the negative
control in the 21 day mineralization study. Nor was there enough evidence to suggest that
the RK-loaded membranes resulted in increased calcium deposition by the cells. This
could be due to the burst release followed by a decreasing rate of RK release from the
membranes. In the initial ALP study, cells were exposed to constant concentrations of
RK for up to seven days that resulted in an increasing expression of ALP as indicator of
osteoblastic differentiation. Additionally, while Takata’s study found an increase in ALP
in the presence of RK, it only examined the effects of RK at constant concentrations from
0-100 μg/ml over 6 days21. However, elution profiles of RK from the membranes
indicated that RK levels were between 50 and 200 μg/ml for between 1 and 3 days,
depending on membrane modification. Even though the HA-treated membranes loaded
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with 500 μg released RK for up to 14 days, release levels dropped below 50 μg/ml by
Day 5, which may be too soon to have stimulated ALP expression and hence
osteodifferentiation. These results suggest that RK-loaded chitosan membranes may have
a similar problem to BMP-2 loaded GBR membranes: the drug is released too quickly to
maintain an effective dosage8. Takata et al. also found that RK at constant concentrations
of 50-100 μg/ml over 6 days induced upregulation of collagen I and osteocalcin in the
presence of the differentiation agent all-trans-retinoic acid (ATRA)21. These effects were
not investigated in the presence of BMP-2. However, the study provides more indication
that RK may induce differentiation and mineralization in W-20-17 cells with higher
concentrations at later time points. Some potential solutions to this problem include
increasing the loading concentration and treating the chitosan membranes with a longer
fatty acid chain. Increasing the loading concentration would increase the amount of drug
released at later time points, but it could lead to unknown side effects and cytotoxicity at
early time points. Treating with a longer fatty acid chain would increase the
hydrophobicity of the membrane and potentially result in a longer, more sustained release
of RK. Additionally, in this in vitro study, the membranes were not in direct contact with
the cells. In vivo the membranes would be in direct contact with bone and may have a
greater effect. In any case, RK remains a potential bioactive agent for osteodifferentiation.
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Conclusion
Electrospun chitosan membranes loaded with raspberry ketone have many of the
properties desired for a guided bone regeneration system. The release of RK from the
chitosan membranes can be predictably manipulated based on the type of fatty acid the
membranes are treated with. RK did not show any cytotoxicity to W-20-17 cells up to a
dosage of 500 μg/membrane. In addition, RK-spiked media appeared to induce
expression of comparable levels of ALP from W-20-17 cells as BMP-2 after 7 days.
However, the mineralization study showed that the RK-loaded membranes did not have a
significant effect on mineralization over 21 days. It is speculated that RK was released
from the membranes too quickly to induce mineralization in the cells. Future work will
explore modifications to extend delivery of RK to maintain active concentrations over a
timeframe relevant to osteodifferentiation, as well as expanded preclinical evaluations in
bone healing models. To conclude, electrospun chitosan membranes loaded with
raspberry ketone may have potential to be used in guided bone regeneration procedures.
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CHAPTER 3: CONCLUSIONS
Electrospun chitosan membranes loaded with raspberry ketone have shown that
they are a promising guided bone regeneration system. Electrospun chitosan membranes
were successfully fabricated and treated using a fatty acid and pyridine solution. RK was
successfully loaded onto the membranes using 200 proof ethanol. This loading technique
could be used at time of care by physicians if desired. The type of fatty acid used in the
post-spinning treatment was shown to manipulate the release pattern of the RK from the
chitosan membrane. This suggests some level of customization is possible and the release
of RK can be either shortened or prolonged. The RK-loaded membranes also showed no
cytotoxicity in vitro, indicating that dosages of up to 500 μg/membrane are safe to use
and are not toxic osteoblastic pre-cursors. RK also appeared to induce expression of ALP
from W-20-17 cells at similar levels as BMP-2 after 7 days of culture. These results
demonstrate that RK could be effective in differentiating osteoblastic precursor cells in a
bone graft site. However, RK-loaded membranes did not show an ability to induce
differentiation or mineralization, likely because the RK was released too quickly to have
an effect. Improvements of RK release from the membranes are necessary to determine
the potential of RK-loaded chitosan membranes for GBR purposes.
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CHAPTER 4: FUTURE WORK
Experiments need to be performed to determine dosing of RK needed to induce
osteoblast differentiation. Then studies will be needed to determine how to deliver RK to
achieve the necessary concentration and time of release. This could be examined by
increasing fatty acid chain length. Alternative mechanisms could be to explore ways to
link RK to chitosan fibers to provide a more sustained release. Previous un-published
results by our group have shown that it may be possible to link RK to chitosan via a
reaction between the ketone of RK and the amine group of the chitosan. Additionally, in
vivo dosing studies will be needed to determine if dosing is the same as in vitro. RK alone
helps to differentiate effects but in vivo there is a complex milieu of factors that may act
in combination with RK to increase osteogenic differentiation. The mechanism of action
of RK will also be investigated. Studies may involve identification of a cell surface
receptor that RK activates or determining whether RK penetrates the cell membrane and
activates some other pathway. Although the effects of RK and BMP-2 together were
briefly investigated, there will be further experiments into whether an interaction exists
that could produce an additive or synergistic effect in osteoblast differentiation and
maturation. In the study performed by Takata et al. the C3H10T1/2 cells only responded
to RK in the presence of 300 ng/ml BMP-2, so higher concentrations of BMP-2 may need
to be tested in conjunction with RK. Other biological roles of RK may also be explored in
the context of bone healing, such as effects on inflammation. RK has already been shown
to have antioxidant effects on cultured monocytes37. The impact of RK on these cells and
the normal inflammatory healing response will be important to understanding the overall
potential for locally delivering RK to stimulate bone healing.
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APPENDICES
Appendix A
Electrospinning Methods
Chitosan from Primex (71% DDA, 311.5 kDa) at 5.5 (w/v) % was dissolved in a
solution containing 70% (v/v) trifluoroacetic acid (TFA) - 30% (v/v) dichloromethane
(DCM). Glass serological pipettes were used because plastic could be dissolved by TFA
or DCM. This solution was gently mixed overnight on a Belly Dancer shaker (Stovall
Life Science, Inc.). The next day, the solution was loaded into a 10 ml syringe with a
blunt 20 gauge needle. The syringe was then loaded onto a syringe pump and the
pumping rate was set for 15 μl/minute. The solution was electrospun with an applied DC
voltage of 26 kV (Figure 4). The chitosan fibers were collected on non-stick aluminum
foil (Reynolds Wrap VR) that was wrapped around a rotating metal collecting plate
(38.1-cm-diameter circular disc). The collector was positioned approximately 15 cm from
the needle tip and rotated at 8.4 RPM by an AC motor to ensure even and random
distribution of fibers. After the entire solution was pumped out of the syringe, the voltage
source was turned off and the foil was removed from the collecting plate. The membrane
could then carefully be removed from the non-stick foil.

Figure 4. A diagram of the electrospinning set up used by our lab.
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Appendix B
HPLC Methods
A mobile phase consisting of 70% [0.124 M monopotassium phosphate
(KH2PO4), 0.08 M dipotassium phosphate (K2HPO4)] and 30% Acetonitrile (CH3CN)
was created for HPLC analysis. A 500 µg RK per 1 mL PBS standard was used. Serial
dilutions were made using this standard to create additional standards of 250, 125, 62.5,
31.25, 15.63, 7.81, 3.91, 1.95, 0.98, 0.49 and 0 μg/ml. The solution was pumped through
a Hypersil GOLD C8 column at a rate of 1 ml/min for 10 minutes. RK showed a peak at
approximately 3.88 minutes, as shown by Figure 10. Using the standard curve, the
average amount of RK (µg/mL) in the PBS and standard deviation were found for each
day and a bar graph was created for each treatment and dosage to observe the release.

Figure 5. The chromatogram produced by running the 500 μg/ml RK standard through
the HPLC at a rate of 1 ml/min.
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Appendix C
Cumulative Release of RK
The elution data were graphed as cumulative release over time (Figure 6). These
graphs were not used because some of the lines overlapped, making it difficult to
distinguish between groups. However, it does illustrate how quickly the membranes
released RK.
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Figure 6. Cumulative release of RK from treated membranes over 14 days (n=4 per
group).
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Appendix D
Additional RK Elution Data
The following data are from a previous RK elution study performed with the help
of Dr. Delbuque Guerra. These study data were not used because the time points were not
consistent with media changes in cell culture. Other than the time points, the procedure
was identical to the methods outlined previously in the thesis. The study was repeated
using time points modeling when growth media would be changed during a culture. This
gives a better estimate of the amount of RK the cells were exposed to in later
experiments. The release profiles of this preliminary data, though, are consistent with the
follow-up study (Figure 7).
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Figure 7. Elution data from preliminary RK release study. Error bars are standard
deviations (n=4 per group).
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Appendix E
Additional ALP Results
The ALP study was attempted previously but the standard deviations were far too
large to use the data. These large standard deviations were likely due to something like
pipetting error. The study was repeated to attempt to decrease error. The data shown
below are from the previous ALP study (Figure 8). The standard deviations of the data
used in the thesis were much smaller.
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Figure 8. ALP data from previous study. Data were not used because standard deviations
were too large.
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